Arlington, MA, United States of America

Thrimurtulu Neetipalli

This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignees: Harvard College, Zikani Therapeutics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thrimurtulu Neetipalli. Retrieved from https://idiyas.com/inventor/thrimurtulu-neetipalli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 19.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thrimurtulu Neetipalli: Innovator in Macrolide Research

Introduction

Thrimurtulu Neetipalli is an accomplished inventor based in Arlington, MA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of macrolide antibiotics. His innovative work focuses on addressing infectious diseases, which is a critical area of research in modern medicine.

Latest Patents

Neetipalli holds a patent for "C10-alkylene substituted 13-membered macrolides and uses thereof." This patent describes 13-membered macrolides that are specifically designed for the treatment of infectious diseases. The macrolides detailed in the patent are azaketolides, which have shown promise in combating infections caused by Gram-negative bacteria. The patent also outlines methods for preparing these macrolides, as well as pharmaceutical compositions that incorporate them.

Career Highlights

Throughout his career, Neetipalli has worked with notable organizations, including Zikani Therapeutics, Inc. and Harvard College. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Neetipalli's coworkers include Shuhao Shi and Ivan Jewett. Their collaborative efforts have further advanced the research and development of macrolide antibiotics.

Conclusion

Thrimurtulu Neetipalli is a prominent figure in the field of medicinal chemistry, with a focus on innovative solutions for treating infectious diseases. His patent on 13-membered macrolides represents a significant advancement in antibiotic research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…